4.7 Article

Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine

R. Schmidt et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Alzheimer disease:: Postmortem neuropathologic correlates of antemortem 1H MR Spectroscopy metabolite measurements

Kejal Kantarci et al.

RADIOLOGY (2008)

Review Clinical Neurology

High field H-1 MRS of the hippocampus after donepezil treatment in Alzheimer disease

Robert Bartha et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)

Article Geriatrics & Gerontology

Longitudinal H-1 MRS changes in mild cognitive impairment and Alzheimer's disease

Kejal Kantarci et al.

NEUROBIOLOGY OF AGING (2007)

Article Geriatrics & Gerontology

Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial

Elaine R. Peskind et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)

Review Biochemistry & Molecular Biology

The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques

Pedro J. Modrego

CURRENT MEDICINAL CHEMISTRY (2006)

Article Radiology, Nuclear Medicine & Medical Imaging

1H MR spectroscopy using TE averaged PRESS:: A more sensitive technique to detect neuro degeneration associated with Alzheimer's disease

I Hancu et al.

MAGNETIC RESONANCE IN MEDICINE (2005)

Article Medicine, General & Internal

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial

PN Tariot et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Article Medicine, General & Internal

Memantine in moderate-to-severe Alzheimer's disease

B Reisberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Neurosciences

Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40)

JJ Miguel-Hidalgo et al.

BRAIN RESEARCH (2002)